Editas Medicine, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-18. The offering totals $120.0M, of which $120.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Kevin Bitterman | Director | Cambridge, MA |
| Alexis Borisy | Director | Boston, MA |
| KATRINE BOSLEY | Director | CAMBRIDGE, MA |
| Douglas Cole | Director | Cambridge, MA |
| Boris Nikolic | Director | Atlanta, GA |
| KATRINE BOSLEY | Executive Officer | CAMBRIDGE, MA |
| Alexandra Glucksmann | Executive Officer | Medford, MA |
| Andrew Hack | Executive Officer | CAMPBELL, CA |
| VIC MYER | Executive Officer | BOSTON, MA |